< LMCC
  • a marked and persistent fear of social or performance situations where one is exposed to unfamiliar people or possible scrutiny

Epidemiology

  • lifetime prevalence rate ~ 16%
  • Female: Male = 1.5: 1
  • Begins in early childhood and adolescence
  • can lead to significant psychiatric comoribidy including depression, anxiety disorders, substance abuse and eating disorders
  • often underrecognized by family practitioners

History

  • fear of being humiliated or embarassed in social or performance situations
    • include: public speaking, eating, drinking, writing, public restrooms, speaking on the telephone, social gatherings
  • the fear is recognized as excessive/unreasonable
  • the avoidance, anticipation and distress interfere significantly with social and occupational functioning
  • often presents with somatic complaints of insomnia, fatigue, palpitations, chest pain, shortness of breath, dizziness, trembling of hands, sweating, blushing and GI complaints

Physical

  • hyperhidrosis, tremor, blushing, stuttering, hypertension and tachycardia
  • must do a thorough mental status examination

Management

  • cognitive behavioural therapy
  • exposure therapy (most firmly established therapeutic maneuver)
  • cognitive restructuring
  • social skills training

Pharmacology

  • effective treatments include MAOI, anxiolytics and SSRIs (drug of choice due to effectiveness and lack of significant side effects)

References

Toronto Notes 2005

This article is issued from Wikiversity. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.